PA-19-053 - NIH Exploratory/Developmental Research Grant Program (Parent R21 Clinical Trial Not Allowed) is used for the submission of applications to the following Notices of Special Interest (NOSIs)

On This Page: 37

Active NOSIs

Title Notice Number Organization Release
Date		 Expiration
Date		 Activity
Code(s)

Expired NOSIs

Title Notice Number Organization Release
Date		 Expiration
Date		 Activity
Code(s)
Notice of Special Interest: NCCIH High Priority Pain Research NOT-AT-22-007 NCCIH Dec 20, 2021 Dec 15, 2022 R01, R21, R15, R34
Notice of Special Interest (NOSI): Advancing Research on SUD through Computational Neuroscience NOT-DA-20-022 NIDA May 5, 2020 Sep 8, 2023 R01, R21
Notice of Special Interest (NOSI): Data Driven Research on Coronavirus Disease 2019 (COVID-19) (R21) NOT-LM-20-011 NLM Apr 27, 2020 Jun 17, 2020 R21
Notice of Special Interest (NOSI): Cannabis, Prescription Opioid, or Prescription Benzodiazepine Drug Use Among Older Adults NOT-DA-20-014 NIDA Apr 22, 2020 Sep 8, 2023 R01, R03, R21
Notice of Special Interest: Promoting Research on Mechanisms of Pathogenesis and Pathophysiology of Atypical Femoral Fracture (AFF) and Osteonecrosis of the Jaw (ONJ) NOT-AR-21-006 NIAMS ORWH NIDCR NIA Apr 15, 2020 Jul 18, 2023 R01, R21
Notice of Special Interest (NOSI): Single-Cell Proteomics for Interrogating Premalignant and Early Malignant Lesions NOT-CA-20-044 NCI Apr 9, 2020 May 8, 2023 R03, R21, R01, P01
Notice of Special Interest (NOSI): Neuroimmune Signaling and Function in Substance Use Disorders NOT-DA-20-046 NIDA Apr 7, 2020 Sep 8, 2023 R01, R21, R15, 333
RESCINDED - Notice of Special Interest (NOSI): Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) NOT-AI-20-031 NIAID Mar 27, 2020 Apr 5, 2021 R03, R21, 333, R01, R43/R44, R41/R42
Notice of Special Interest (NOSI): Exploring the Roles of Biomolecular Condensates (BMCs) in Substance Use Disorder and/or HIV-related processes NOT-DA-20-018 NIDA Mar 25, 2020 Sep 8, 2023 R01, R03, R21, 333
Notice of Special Interest (NOSI):Sleep and Substance Use Disorders NOT-DA-20-021 NIDA Mar 25, 2020 Sep 8, 2023 R01, R03, R21, K99/R00, R61/R33
Notice of Special Interest (NOSI): Research to Improve the Interpretation of Patient-Reported Outcomes at the Individual Patient Level for Use in Clinical Practice NOT-OD-20-079 OBSSR ODP NIAAA NINDS NINR NHGRI NIDCD NIAMS NCCIH NCI NIMH NIMHD ORWH NIA Mar 24, 2020 Jan 8, 2022 R21, R01
Notice of Special Interest (NOSI): Competitive Revisions for Firearms Injury and Mortality Prevention Research NOT-OD-20-089 OBSSR NIA NICHD NIMH NCCIH ODP NIMHD ORWH NIAAA Mar 20, 2020 May 16, 2020 R01, R21
Notice of Special Interest: Alcohol and Cancer Control NOT-CA-20-034 NCI Mar 19, 2020 Sep 9, 2023 R01, R21, R03, 333
Notice of Special Interest (NOSI): Advancing Head and Neck Cancer Early Detection Research (AHEAD) NOT-CA-20-031 NCI NIDCR Mar 10, 2020 Jan 8, 2022 R03, R21, R01
Notice of Special Interest (NOSI): Effects of Cannabis Use and Cannabinoids on the Developing Brain NOT-DA-20-039 NIDA Mar 5, 2020 Sep 8, 2023 R01, R03, R21
Notice of Special Interest (NOSI): Mechanistic Investigations of Psychosocial Factors Associated with Substance Use Disorders NOT-DA-20-005 NIDA Mar 3, 2020 Sep 8, 2023 R01, R21
Notice of Special Interest (NOSI): Going Global: Using Gene Network Analyses to Understand the Etiology of SUD NOT-DA-20-020 NIDA Feb 26, 2020 Sep 8, 2023 R01, R03, R21, 333
Notice of Special Interest (NOSI): Research on Oral Anticancer Agents in the Contexts of Utilization, Adherence, and Health Care Delivery NOT-CA-20-026 NCI Feb 21, 2020 May 8, 2023 R01, R21, R03, P01
Notice of Special Interest (NOSI): Drug-drug interactions among substances of abuse, medications to treat HIV infection, and pharmacotherapies to treat substance use disorders NOT-DA-20-013 NIDA Feb 6, 2020 May 8, 2022 R01, R03, R21
Notice of Special Interest (NOSI): Transcriptomic, epigenomic, regulatory RNA or functional genomic research in Substance Use Disorders NOT-DA-20-031 NIDA Feb 6, 2020 Jan 8, 2023 R01, R03, R21, 333, R21/R33
Notice of Special Interest (NOSI): Use of Biological "High" or "Medium" Priority AIDS Research on Non-AIDS-defining or AIDS-defining Cancers NOT-CA-20-022 NCI Jan 15, 2020 Jan 8, 2023 R01, R21, R03
Notice of Special Interest: Development of Statistical, Population Genetics and Computational Methods Related to Polygenic Prediction of Health and Disease in Diverse Populations NOT-HG-20-010 NHGRI NCI NHLBI Jan 13, 2020 Oct 5, 2023 R01, R21, R03
Notice of Special Interest (NOSI): Preclinical and Clinical Studies of the Interactions of Opioids and Stimulants NOT-DA-20-007 NIDA Jan 6, 2020 Jun 5, 2023 R03, R21, R01
Notice of Special Interest (NOSI): Modeling Social Contagion of Substance Use Epidemics NOT-DA-20-009 NIDA Jan 2, 2020 Jan 8, 2023 R01, R03, R21
Notice of Special Interest (NOSI): Advancing Development of Rapid Point-of-Care Hepatitis C Virus Diagnostics NOT-AI-20-013 NIAID NIBIB Dec 17, 2019 Jan 8, 2023 R43/R44, R41/R42, R21, R01
Notice of Special Interest: Exploring the Mechanisms Underlying Analgesic Properties of Minor Cannabinoids and Terpenes NOT-AT-20-002 NCCIH Dec 13, 2019 Jan 8, 2022 R01, R21
Notice of Special Interest: Promoting research opportunities on HIV/AIDS in NIAMS NOT-AR-20-005 NIAMS Oct 22, 2019 Jan 10, 2023 R01, R21, 333
Notice of Special Interest: High-Priority Research Topics for PA-19-053 and PA-19-056 NOT-AG-19-037 NIA NIAMS Sep 4, 2019 Jan 8, 2022 R21, R01
Notice of Special Interest (NOSI) of NIDCD and NEI in Supporting Research on Usher Syndrome NOT-DC-19-007 NIDCD NEI Sep 4, 2019 Jan 8, 2022 U01, R01, R21, R24, P50, UG1
Notice of Special Interest (NOSI): Epidemiology of Drug Abuse NOT-DA-19-066 NIDA Aug 29, 2019 Jan 8, 2022 R01, R21, R03, 333
Notice of Special Interest (NOSI): Public Health Research on Cannabis NOT-DA-19-065 NIDA Aug 14, 2019 Jan 8, 2022 R01, R21, R03, 333
Notice of Special Interest (NOSI): The Application of Big Data Analytics to Drug Abuse Research NOT-DA-19-041 NIDA Jul 12, 2019 Jan 8, 2022 R01, R21, R03
Notice of Special Interest (NOSI): Health Services and Economic Research on the Treatment of Drug, Alcohol, and Tobacco Use Disorders (R01, R21, R03) NOT-DA-19-037 NIDA Jul 11, 2019 Sep 8, 2022 R01, R21, R03
Notice of Special Interest (NOSI): Research to Prevent Drug Use, Misuse and Addiction NOT-DA-19-048 NIDA Jul 10, 2019 Jan 8, 2022 R01, R21, R03
Notice of Special Interest (NOSI): Gene-Environment Interplay in Substance Use Disorders (R01, R21) NOT-DA-19-038 NIDA Jul 10, 2019 Jan 8, 2022 R01, R21
Notice of Special Interest (NOSI): Bold New Bioengineering Research for Heart, Lung, Blood and Sleep Disorders and Diseases NOT-HL-19-678 NHLBI Mar 14, 2019 Jan 8, 2022 R21
Notice of Availability of Competitive Supplements/Revisions for the INCLUDE (Investigation of Co-occurring Conditions across the Lifespan to Understand Down syndromE) Project (Competitive Supplement/Revision Clinical Trial Optional) NOT-OD-19-071 NIH Feb 5, 2019 Mar 17, 2019 R01, R03, R21, U01
For technical issues E-mail OER Webmaster